BRIEF published on 07/29/2026 at 23:05, 2 months 24 days ago Biophytis : Publication des comptes annuels 2025 et reprise de la cotation Biophytis Trésorerie Cotation Boursière Incertitude Financière Résultats Financiers 2025
BRIEF published on 07/29/2026 at 23:05, 2 months 24 days ago NiobiumX Mining Inc. Begins Trading Under "NIOX" on Canadian Securities Exchange Critical Minerals Niobium Exploration Marketing Agreements Shipshaw Property NiobiumX Trading
BRIEF published on 07/29/2026 at 23:05, 2 months 24 days ago NiobiumX Mining Inc. commence à être négociée sous le symbole « NIOX » à la Bourse canadienne des valeurs mobilières Minéraux Critiques Exploration Du Niobium Accords De Marketing Propriété Shipshaw NiobiumX Trading
BRIEF published on 07/29/2026 at 22:05, 2 months 24 days ago Rocky Shore Gold Ltd. Announces Board Changes Board Of Directors Newfoundland Rocky Shore Gold Gold Anchor Project Alex Crosbie
BRIEF published on 07/29/2026 at 22:05, 2 months 24 days ago Rocky Shore Gold Ltd. annonce des changements au sein de son conseil d'administration Conseil D'administration Terre-Neuve Or De La Côte Rocheuse Projet Gold Anchor Alex Crosbie
BRIEF published on 07/29/2026 at 22:05, 2 months 24 days ago Inventiva Releases Preliminary Financial Results for H1 2026 Cash Flow Biopharmaceutical Inventiva R&D Expenses Financial Results 2026
BRIEF published on 07/29/2026 at 22:05, 2 months 24 days ago Inventiva publie ses résultats financiers préliminaires pour le premier semestre 2026 Biopharmaceutique Des Flux De Trésorerie Inventive Dépenses De R&D Résultats Financiers 2026
BRIEF published on 07/29/2026 at 21:50, 2 months 24 days ago Piramal Pharma Limited Reports Strong Q1 FY27 Results Revenue Growth EBITDA Margin Piramal Pharma Q1 FY27 Results US FDA Inspection
BRIEF published on 07/29/2026 at 21:50, 2 months 24 days ago Piramal Pharma Limited annonce de solides résultats pour le premier trimestre de l'exercice 2027 Croissance Des Revenus Marge D'EBITDA Piramal Pharma Résultats Du T1 De L'exercice 2027 Inspection De La FDA Américaine
BRIEF published on 07/29/2026 at 21:17, 2 months 24 days ago Sirma Group Releases Interim Financial Report for H1 2026 Financial Report EQS News Corporate Announcement Sirma Group First Half 2026
Published on 10/23/2026 at 02:20, 3 hours 39 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 6 hours 29 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 7 hours 29 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 13 hours 59 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 15 hours 29 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 4 hours 3 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 7 hours 48 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 9 hours 59 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 10 hours 14 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 11 hours 13 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 11 hours 59 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 11 hours 59 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 11 hours 59 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 11 hours 59 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 11 hours 59 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
